Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112].
Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G.
Kanlikilicer P, et al. Among authors: sood ak.
EBioMedicine. 2020 Feb;52:102630. doi: 10.1016/j.ebiom.2020.102630. Epub 2020 Jan 20.
EBioMedicine. 2020.
PMID: 31972470
Free PMC article.
No abstract available.